自己投与非経口剤の世界市場レポート 2025年

自己投与非経口剤の市場規模は、今後数年間で安定した成長が見込まれます。2029年には年間平均成長率（CAGR）4.6%で311億8,000万米ドルに成長します。予測期間の成長は、在宅ヘルスケアに対する患者の嗜好の高まり、遠隔医療と遠隔患者モニタリング、患者教育と支援イニシアティブ、個別化医療の拡大に起因すると考えられます。予測期間の主な動向には、デジタルヘルスソリューションの統合、カスタマイズされたドラッグデリバリーシステム、標的療法の出現、生物製剤の進歩などがあります。

予測される慢性疾患の増加は、今後の自己投与非経口剤市場の拡大を促進すると予測されます。慢性疾患は、進行が遅く、継続的な管理と治療が必要であることを特徴とする永続的な病状です。自己投与非経口剤製品は、慢性疾患の治療において、内服薬と比較してアドヒアランスを大幅に向上させ、個人が独自に治療を管理できるようにすることで重要な役割を果たしています。例えば、2023年1月に米国国立衛生研究所が発表したデータによると、50歳以上の高齢者のうち、少なくとも1つの慢性疾患の有病率は、2020年の7,152万2,000人から2050年には1億4,266万人へと99.5%急増すると予想されています。その結果、慢性疾患の罹患率の上昇が自己投与非経口剤市場の成長を促進する主要因となっています。

自己投与非経口剤市場の主要企業は、患者の選択と管理を強化し、治療へのアクセスを向上させるため、UDENYCA自動注射器のような革新的な製品の開発に注力しています。自動注射器は、特定の薬剤を1回分ずつ投与するように設計された医療機器であり、皮膚を押すだけで即座に確実に投与が開始される直感的なデザインが特徴です。例えば、2023年5月、米国のバイオテクノロジー企業であるCoherus BioSciences Inc.は、自己投与非経口剤薬であるUDENYCAオートインジェクターを米国市場に投入しました。UDENYCA Autoinjectorは、ペグフィルグラスチムの新たな投与オプションを患者に提供する、1回投与タイプのプレフィルドオートインジェクターです。プッシュ・オン・スキンで作動する直感的なデザインにより、ペグフィルグラスチム全用量を確実かつ迅速に投与することができます。さらに、迅速な投与、直感的なデザイン、家庭内およびオフィスでの使用のためのデュアルカバレッジ、発熱性好中球減少症のリスクの低減など、様々なユーザーフレンドリーな機能が組み込まれており、全体的な治療経験を向上させます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界自己投与非経口剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の自己投与非経口剤市場：成長率分析
• 世界の自己投与非経口剤市場の実績：規模と成長, 2019-2024
• 世界の自己投与非経口剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界自己投与非経口剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の自己投与非経口剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレフィルドシリンジ
• オートインジェクター
• ペン型注射器
• その他の製品
• 世界の自己投与非経口剤市場用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨て
• 再利用可能
• 世界の自己投与非経口剤市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 在宅ヘルスケア提供者
• 専門クリニック
• その他の流通チャネル
• 世界の自己投与非経口剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管疾患
• 糖尿病
• 骨粗鬆症
• 疼痛管理
• ホルモン補充療法
• その他の用途
• 世界の自己投与非経口剤市場、プレフィルドシリンジの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガラス充填済み注射器
• プラスチック充填済み注射器
• 世界の自己投与非経口剤市場、タイプ別の自動注射器のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨て自動注射器
• 再利用可能なオートインジェクター
• 世界の自己投与非経口剤市場ペン型注射器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• インスリンペン型注射器
• 成長ホルモンペン注射器
• その他のペン型注射器
• 世界の自己投与非経口剤市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 輸液ポンプ
• 無針注射器
• 複合デバイス

第7章 地域別・国別分析

• 世界の自己投与非経口剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の自己投与非経口剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 自己投与非経口剤市場：競合情勢
• 自己投与非経口剤市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Roche Holding AG
• Eli Lilly and Company
• Novo Nordisk A/S
• Becton, Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Terumo Corporation
• Catalent Inc.
• Dexcom Inc.
• West Pharmaceutical Services Inc.
• Gerresheimer AG
• Biocon Limited
• Insulet Corporation
• Halozyme Therapeutics Inc.
• Ypsomed AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 自己投与非経口剤市場2029：新たな機会を提供する国
• 自己投与非経口剤市場2029：新たな機会を提供するセグメント
• 自己投与非経口剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Self-administered parenteral refers to the practice of administering medication or ssubstances directly into the body through injection methods by the individual themselves. This approach grants patients increased independence and convenience, enabling them to manage their conditions in a flexible and comfortable manner without frequent visits to healthcare facilities.

The primary products in self-administered parenterals include pre-filled syringes, autoinjectors, pen injectors, and others. Pre-filled syringes are pre-loaded medical devices designed for the delivery of liquid medications. They are available as both disposable and reusable options and are distributed through various channels including hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, among others. These products are utilized in the treatment of conditions such as cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement therapy, and others.

The self-administered parenteral market research report is one of a series of new reports from The Business Research Company that provides self-administered parenteral market statistics, including self-administered parenteral industry global market size, regional shares, competitors with a self-administered parenteral market share, detailed self-administered parenteral market segments, market trends and opportunities, and any further data you may need to thrive in the self-administered parenteral industry. This self-administered parenteral market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-administered parenteral market size has grown strongly in recent years. It will grow from $24.57 billion in 2024 to $26.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rise in chronic diseases, aging population, government initiatives, patient education and support programs, the rising incidences of bone disorders.

The self-administered parenteral market size is expected to see steady growth in the next few years. It will grow to $31.18 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing patient preference for home healthcare, telemedicine and remote patient monitoring, patient education and support initiatives, growing personalized medicine. Major trends in the forecast period include integration of digital health solutions, customized drug delivery systems, emergence of targeted therapies, advancements in biologics.

The projected rise in chronic diseases is anticipated to drive the expansion of the self-administered parenteral market in the future. Chronic diseases are enduring medical conditions characterized by slow progression and necessitate ongoing management and treatment. Self-administered parenteral products play a crucial role in managing chronic diseases by enabling individuals to independently administer treatment, thereby significantly enhancing adherence compared to oral medication. For instance, data from the National Institutes of Health in January 2023 revealed that among individuals aged 50 or older, the prevalence of at least one chronic disease is expected to surge by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Consequently, the escalating incidence of chronic diseases serves as a key driver fueling the growth of the self-administered parenteral market.

Major players in the self-administered parenteral market are concentrating on the development of innovative products such as the UDENYCA autoinjector to enhance patient choice and control, thereby improving treatment accessibility. An autoinjector is a medical device engineered to deliver a single dose of a specific drug, featuring an intuitive design where administration is triggered immediately and reliably by push-on-skin activation. For instance, in May 2023, Coherus BioSciences Inc., a US-based biotech company, introduced the UDENYCA autoinjector, a self-administered parenteral medication in the US market. The UDENYCA Autoinjector is a single-dose, prefilled autoinjector offering patients an additional administration option for pegfilgrastim. Its intuitive design, activated by push-on-skin, ensures reliable and immediate delivery of a full pegfilgrastim dose. Moreover, it incorporates various user-friendly features such as rapid dosing, intuitive design, dual coverage for at-home and in-office use, and a reduction in the risk of febrile neutropenia, thereby enhancing the overall treatment experience.

In May 2022, Halozyme Therapeutics Inc., a biotechnology company headquartered in the United States, finalized the acquisition of Antares Pharma Inc. for $960 million. Through this transaction, Halozyme aims to leverage Antares' foundational platform technologies and capabilities, intending to establish a leading specialty product and medicine delivery company by expanding its portfolio in this sector. Antares Pharma Inc., also based in the US, specializes in the manufacturing of self-administered parenteral medications.

Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG

North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-administered parenteral market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self-administered parenteral market consists of sales of biologic drugs, blood thinners, fertility drugs, osteoporosis medications, and insulin and inhaler devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Self-Administered Parenteral Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-administered parenteral market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-administered parenteral ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The self-administered parenteral market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Pre-Filled Syringes; Autoinjectors; Pen Injectors; Other Products
• 2) By Usage: Disposable; Reusable
• 3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Home Healthcare Providers; Specialty Clinics; Other Distribution Channels
• 4) By Application: Cardiovascular Diseases; Diabetes; Osteoporosis; Pain Management; Hormone Replacement; Other Applications
• Subsegments:
• 1) By Pre-Filled Syringes: Glass Pre-Filled Syringes; Plastic Pre-Filled Syringes
• 2) By Autoinjectors: Disposable Autoinjectors; Reusable Autoinjectors
• 3) By Pen Injectors: Insulin Pen Injectors; Growth Hormone Pen Injectors; Other Pen Injectors
• 4) By Other Products: Infusion Pumps; Needle-Free Injectors; Combination Devices
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Self-Administered Parenteral Market Characteristics

3. Self-Administered Parenteral Market Trends And Strategies

4. Self-Administered Parenteral Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Self-Administered Parenteral Growth Analysis And Strategic Analysis Framework

• 5.1. Global Self-Administered Parenteral PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Self-Administered Parenteral Market Growth Rate Analysis
• 5.4. Global Self-Administered Parenteral Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Self-Administered Parenteral Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Self-Administered Parenteral Total Addressable Market (TAM)

6. Self-Administered Parenteral Market Segmentation

• 6.1. Global Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Filled Syringes
• Autoinjectors
• Pen Injectors
• Other Products
• 6.2. Global Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disposable
• Reusable
• 6.3. Global Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Online Pharmacies
• Home Healthcare Providers
• Specialty Clinics
• Other Distribution Channels
• 6.4. Global Self-Administered Parenteral Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Diabetes
• Osteoporosis
• Pain Management
• Hormone Replacement
• Other Applications
• 6.5. Global Self-Administered Parenteral Market, Sub-Segmentation Of Pre-Filled Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glass Pre-Filled Syringes
• Plastic Pre-Filled Syringes
• 6.6. Global Self-Administered Parenteral Market, Sub-Segmentation Of Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disposable Autoinjectors
• Reusable Autoinjectors
• 6.7. Global Self-Administered Parenteral Market, Sub-Segmentation Of Pen Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Pen Injectors
• Growth Hormone Pen Injectors
• Other Pen Injectors
• 6.8. Global Self-Administered Parenteral Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infusion Pumps
• Needle-Free Injectors
• Combination Devices

7. Self-Administered Parenteral Market Regional And Country Analysis

• 7.1. Global Self-Administered Parenteral Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Self-Administered Parenteral Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Self-Administered Parenteral Market

• 8.1. Asia-Pacific Self-Administered Parenteral Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Self-Administered Parenteral Market

• 9.1. China Self-Administered Parenteral Market Overview
• 9.2. China Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Self-Administered Parenteral Market

• 10.1. India Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Self-Administered Parenteral Market

• 11.1. Japan Self-Administered Parenteral Market Overview
• 11.2. Japan Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Self-Administered Parenteral Market

• 12.1. Australia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Self-Administered Parenteral Market

• 13.1. Indonesia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Self-Administered Parenteral Market

• 14.1. South Korea Self-Administered Parenteral Market Overview
• 14.2. South Korea Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Self-Administered Parenteral Market

• 15.1. Western Europe Self-Administered Parenteral Market Overview
• 15.2. Western Europe Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Self-Administered Parenteral Market

• 16.1. UK Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Self-Administered Parenteral Market

• 17.1. Germany Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Self-Administered Parenteral Market

• 18.1. France Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Self-Administered Parenteral Market

• 19.1. Italy Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Self-Administered Parenteral Market

• 20.1. Spain Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Self-Administered Parenteral Market

• 21.1. Eastern Europe Self-Administered Parenteral Market Overview
• 21.2. Eastern Europe Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Self-Administered Parenteral Market

• 22.1. Russia Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Self-Administered Parenteral Market

• 23.1. North America Self-Administered Parenteral Market Overview
• 23.2. North America Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Self-Administered Parenteral Market

• 24.1. USA Self-Administered Parenteral Market Overview
• 24.2. USA Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Self-Administered Parenteral Market

• 25.1. Canada Self-Administered Parenteral Market Overview
• 25.2. Canada Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Self-Administered Parenteral Market

• 26.1. South America Self-Administered Parenteral Market Overview
• 26.2. South America Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Self-Administered Parenteral Market

• 27.1. Brazil Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Self-Administered Parenteral Market

• 28.1. Middle East Self-Administered Parenteral Market Overview
• 28.2. Middle East Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Self-Administered Parenteral Market

• 29.1. Africa Self-Administered Parenteral Market Overview
• 29.2. Africa Self-Administered Parenteral Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Self-Administered Parenteral Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Self-Administered Parenteral Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Self-Administered Parenteral Market Competitive Landscape And Company Profiles

• 30.1. Self-Administered Parenteral Market Competitive Landscape
• 30.2. Self-Administered Parenteral Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Self-Administered Parenteral Market Other Major And Innovative Companies

• 31.1. Roche Holding AG
• 31.2. Eli Lilly and Company
• 31.3. Novo Nordisk A/S
• 31.4. Becton, Dickinson and Company
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Mylan N.V.
• 31.7. Terumo Corporation
• 31.8. Catalent Inc.
• 31.9. Dexcom Inc.
• 31.10. West Pharmaceutical Services Inc.
• 31.11. Gerresheimer AG
• 31.12. Biocon Limited
• 31.13. Insulet Corporation
• 31.14. Halozyme Therapeutics Inc.
• 31.15. Ypsomed AG

32. Global Self-Administered Parenteral Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Self-Administered Parenteral Market

34. Recent Developments In The Self-Administered Parenteral Market

35. Self-Administered Parenteral Market High Potential Countries, Segments and Strategies

• 35.1 Self-Administered Parenteral Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Self-Administered Parenteral Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Self-Administered Parenteral Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer